73/100B904.38
USD
1.56
(0.17%)
Pre Open·910.20USD+5.82(+0.64%)
Last updated: · Delayed 15 min
Fair value814.64Plus+11%346Price 904.381,431
Q4 FY2026 · Earnings report
EPS estimate 25.39Revenue estimate 5.85B
Q4 FY2026 · Earnings report
EPS estimate 25.39Revenue estimate 5.85B
Who owns Regeneron Pharmaceuticals?What is institutional ownership? Institutional ownership is the share of a company's stock held by funds, banks and other investment managers, as they report it each quarter on Form 13F.
Institutions own 89.3% of Regeneron Pharmaceuticals's shares, through 1,397 funds, banks and other managers that report their holdings to the SEC; individual investors and others hold the rest. The largest on 30 June 2026 were BlackRock, Inc. (8.8%), Vanguard Capital Management LLC (6.4%), Dodge & Cox (4.7%).
- Institutions ownWhat is institutional ownership? Institutional ownership is the share of a company's stock held by funds, banks and other investment managers, as they report it each quarter on Form 13F.
- 89.3%
- Institutional holders
- 1,397
- The 10 largest hold
- 42.3%
- Free floatWhat is free float? Free float is the part of a company's shares that anyone can buy and sell: all its shares minus those held by insiders, founders and owners of over 5%.
- 96.2%
- Holdings as of
- 30 Jun 2026
Who owns the shares
10 largest holders 42.3% Other institutions 47.0% Individuals and others 10.7%
Shares free to trade
Free float 99.55M shares ·96.2% Closely held 3.88M shares ·3.8%
Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.
The largest shareholders
| # | Holder | Shares | Of the company | Value | Change last quarter (shares) |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 9,113,506 | 8.81% | 5.68B USD | +165,771 |
| 2 | Vanguard Capital Management LLC | 6,629,759 | 6.41% | 4.13B USD | -25,154 |
| 3 | Dodge & Cox | 4,871,137 | 4.71% | 3.04B USD | +412,899 |
| 4 | State Street Corp | 4,834,688 | 4.65% | 3.01B USD | +170,210 |
| 5 | Invesco Ltd. | 3,940,665 | 3.81% | 2.46B USD | +1,760,034 |
| 6 | JPMorgan Chase & Co | 3,774,199 | 3.65% | 2.38B USD | -537,607 |
| 7 | Vanguard Portfolio Management LLC | 3,175,313 | 3.07% | 1.98B USD | +1,454,539 |
| 8 | Franklin Templeton Inc | 2,771,839 | 2.68% | 1.73B USD | +49,768 |
| 9 | Geode Capital Management, LLC | 2,625,810 | 2.54% | 1.63B USD | +18,078 |
| 10 | Nuveen, LLC | 2,019,974 | 1.95% | 1.26B USD | -45,090 |
| 11 | Loomis Sayles & Co L P | 1,859,172 | 1.80% | 1.16B USD | -53,138 |
| 12 | Price T Rowe Associates Inc | 1,529,709 | 1.48% | 953.84M USD | -647,818 |
| 13 | Morgan Stanley | 1,397,712 | 1.35% | 871.53M USD | +78,383 |
| 14 | Bank Of America Corp | 1,291,053 | 1.25% | 805.02M USD | +101,469 |
| 15 | Wellington Management Group LLP | 1,270,087 | 1.23% | 791.95M USD | -567,372 |
| 16 | Norges Bank | 1,172,808 | 1.13% | 731.29M USD | New position |
| 17 | Goldman Sachs Group Inc | 1,163,191 | 1.12% | 725.30M USD | -137,367 |
| 18 | Aqr Capital Management LLC | 1,126,080 | 1.09% | 702.16M USD | -104,928 |
| 19 | Amundi | 1,013,540 | 0.98% | 631.98M USD | +3,742 |
| 20 | Northern Trust Corp | 916,467 | 0.89% | 571.45M USD | -25,474 |
| 21 | Charles Schwab Investment Management Inc | 846,306 | 0.82% | 527.71M USD | +41,798 |
| 22 | Sixth Street Partners Management Company, L.P. | 846,306 | 0.82% | 527.71M USD | New position |
| 23 | FMR LLC | 831,964 | 0.80% | 518.76M USD | -686,228 |
| 24 | Capital World Investors | 814,925 | 0.79% | 508.14M USD | -604,075 |
| 25 | Legal & General Group PLC | 759,971 | 0.74% | 473.87M USD | +27,917 |
All institutions last quarter
- Bought or added
- 732 · 124 new
- Sold or cut
- 733 · 186 sold out
- Net shares bought
- +3.51M · 2.19B USD
- Institutional ownership
- 85.4% → 89.3%
Biggest buyers last quarter
- Invesco Ltd.+1,760,034
- Vanguard Portfolio Management LLC+1,454,539
- Norges BankNew position
- Sixth Street Partners Management Company, L.P.New position
- Dodge & Cox+412,899
Biggest sellers last quarter
- FMR LLC-686,228
- Price T Rowe Associates Inc-647,818
- Capital World Investors-604,075
- Wellington Management Group LLP-567,372
- JPMorgan Chase & Co-537,607
From the holders' 13F filings with the SEC for the quarter to 30 Jun 2026, filed up to 45 days after it; the buyers and sellers are among the 100 largest holders.
Common questions about Regeneron Pharmaceuticals's shareholders
Source: Financial Modeling Prep